Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 191-200 of 444 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Study Of JANX007 In Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study To Evaluate Enfortumab Vedotin To Treat Metastatic Squamous Cell Carcinoma Of The Penis

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Phase 3 Study Of T-DXd And Rilvegostomig Versus SoC In Advanced HER2-expressing Biliary Tract Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Vaccine Therapy Plus Pembrolizumab In Treating Advanced Ovarian, Fallopian Tube, Or Primary Peritoneal Cavity Cancer (FRAPPE)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study To Evaluate Safety, PK, PD And Efficacy Of AZD5492, A T Cell-engaging Antibody Targeting CD20 In Subjects With R/R B-Cell Malignancies.

    Rochester, MN

  6. SUPRAME-ACTengine® IMA203 Vs. Investigator's Choice Of Treatment In Previously Treated, Unresectable Or Metastatic Cutaneous Melanoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Iberdomide, Daratumumab, Bortezomib, And Dexamethasone For Treatment Of Newly Diagnosed Multiple Myeloma, IDEAL Study

    Rochester, MN

  8. A Study Of Prehabilitation In Patients With Multiple Myeloma Receiving CAR-T Therapy

    Rochester, MN

  9. A Study for Cerebral Open Flow Microperfusion

    Rochester, MN

  10. A Study To Compare Standard Therapy To Treat Hodgkin Lymphoma To The Use Of Two Drugs, Brentuximab Vedotin And Nivolumab

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer